Silver Sulfadiazine Encapsulated in Lipid-Based Nanocarriers for Burn Treatment

J Burn Care Res. 2018 Apr 20;39(3):319-325. doi: 10.1097/BCR.0000000000000602.

Abstract

Burn injuries are at risk of bacterial infection because of the damaged skin and reduced immune responses. Silver sulfadiazine, a potent antibacterial agent, is considered as a standard therapy for burn treatment. Recent advances in nanotechnology have had an immense impact on drug delivery systems particularly in burn healing. Lipid-based nanocarriers have been considered as efficient drug delivery systems for burn treatment. This review presents a comprehensive overview of silver sulfadiazine-based nanocarriers and their application in the conservative healing of burn wounds.

MeSH terms

  • Administration, Topical
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Burns / drug therapy*
  • Conservative Treatment
  • Drug Carriers / administration & dosage
  • Drug Carriers / therapeutic use*
  • Humans
  • Liposomes
  • Silver Sulfadiazine / administration & dosage
  • Silver Sulfadiazine / therapeutic use*
  • Wound Healing / drug effects
  • Wound Infection / prevention & control*

Substances

  • Anti-Bacterial Agents
  • Drug Carriers
  • Liposomes
  • Silver Sulfadiazine